Duality Biologics and Avenzo Ink Exclusive License for DB-1418/AVZO-1418
On January 8, Duality Biologics, Inc. (Duality Bio) and Avenzo Therapeutics, Inc. (Avenzo) jointly announced...
Deals
Avenzo Therapeutics Licenses Duality Biologics’ EGFR/HER3 Bispecific ADC AVZO-1418/DB-1418
US-based oncology-focused biotech Avenzo Therapeutics, Inc. has signed a licensing agreement with Duality Biologics, an...
Inceptor Bio and GRIT Biotechnology Partner to Advance CAR-T Therapy IB-T101 for Solid Tumors
US-based Inceptor Bio has entered into a partnership with Chinese firm GRIT Biotechnology to advance...
Kexing and Kelun Partner to Expand Overseas Business for Generic Drugs and Therapies
China-based firms Kexing Pharmaceutical (SHA: 688136) and Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) have...
PKU 1st Hospital Partners with Baheal Pharmaceutical on Integrin-Targeted Inhibitor Project
Peking University First Hospital (PKU 1st Hospital) has partnered with China-based health services and distribution...
Takeda and Fudan University’s IMI Launch AI-Based Rare Disease Screening and Diagnosis Project
Japan-headquartered Takeda (TYO: 4502) and the Intelligent Medicine Institute (IMI) at Fudan University have jointly...
LinkedCare Raises Hundreds of Millions in Series E Funding Led by State-Owned Investors
LinkedCare, a consumer healthcare SaaS+ supply chain platform based in Shanghai, has reportedly raised “hundreds...
Grand Life Sciences Partners with Cali Biosciences for CPL-01 Commercialization in China
China-based Grand Life Sciences has entered into a partnership with compatriot firm Cali Biosciences Co.,...
GlycoNex Licenses SPD8 Biosimilar to Undisclosed Company for Osteoporosis Treatment
Taiwan-based GlycoNex, Inc. (TPEx: 4168) has announced a licensing agreement with an undisclosed company for...
Boehringer Ingelheim and Sutro Achieve Commercial-Scale Manufacturing of Luvelta
Boehringer Ingelheim BioXcellence and Sutro Biopharma Inc. have announced the successful application of Sutro’s proprietary...
Variant Bio Partners with Novo Nordisk to Discover Novel Targets for Metabolic Diseases
US-based genomics start-up Variant Bio has announced a multi-year partnership deal with Novo Nordisk (NYSE:...
AbbVie Exercises Option for Capsida’s Neurodegenerative Disease Program
US-based Capsida Biotherapeutics has announced that its partner AbbVie (NYSE: ABBV) has exercised its option...
PostEra Expands Partnership with Pfizer to Launch New ADC Collaboration
PostEra, a Boston-based biotech company powered by machine learning, has announced an expanded partnership with...
Merck KGaA Adopts Quris AI’s Bio-AI Platform for Drug Development Pipeline
Quris AI, an artificial intelligence (AI) pharmaceutical company based in Boston and Tel-Aviv, has announced...
Boehringer Ingelheim China and Shanghai Pharmaceuticals Holding Co. Launch Strategic Partnership for Linagliptin
On January 7, Boehringer Ingelheim China and Shanghai Pharmaceuticals Holding Co., Ltd. (SPH, HKG: 2607,...
Merck KGaA Completes Acquisition of HUB Organoids, Expanding Cell Culture Portfolio
German major Merck KGaA (ETR: MRK) announced the completion of its acquisition of Holland-based HUB...
Mabwell Bioscience Files for IPO on Hong Kong Stock Exchange, Expanding Biopharma Reach
Mabwell (Shanghai) Bioscience Co., Ltd. (SHA: 688062) has officially filed for an initial public offering...
WuXi Biologics to Sell Irish Vaccine Assets to MSD for USD 500 Million
China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) is poised to...
Hengrui Pharmaceuticals Files IPO Prospectus in Hong Kong Amid Record Deal-Making
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has officially submitted an initial public offering (IPO)...
Changchun BCHT Partners with Baosight Software for Biopharmaceutical Digitization
China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced a partnership with compatriot firm...